Impediments to parallel trade in pharmaceuticals within the European Community: final report
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | Undetermined |
Veröffentlicht: |
Luxembourg
Office for Official Publ. of the Europ. Communities
1992
|
Schriftenreihe: | Document / Commission of the European Communities
Deadline 92 |
Schlagworte: | |
Beschreibung: | 85 S. graph. Darst. |
ISBN: | 9282636607 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV006154902 | ||
003 | DE-604 | ||
005 | 19930817 | ||
007 | t | ||
008 | 930201s1992 d||| |||| 00||| und d | ||
020 | |a 9282636607 |9 92-826-3660-7 | ||
035 | |a (OCoLC)231433291 | ||
035 | |a (DE-599)BVBBV006154902 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | |a und | ||
049 | |a DE-355 |a DE-384 |a DE-12 | ||
084 | |a PS 2860 |0 (DE-625)139739: |2 rvk | ||
084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
245 | 1 | 0 | |a Impediments to parallel trade in pharmaceuticals within the European Community |b final report |c prepared for DGIV of the European Commission by REMIT Consultants, London |
264 | 1 | |a Luxembourg |b Office for Official Publ. of the Europ. Communities |c 1992 | |
300 | |a 85 S. |b graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 0 | |a Document / Commission of the European Communities | |
490 | 0 | |a Deadline 92 | |
610 | 2 | 7 | |a Europäische Gemeinschaften |0 (DE-588)35439-9 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittelmarkt |0 (DE-588)4003131-7 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittelhandel |0 (DE-588)4143178-9 |2 gnd |9 rswk-swf |
651 | 7 | |a Großbritannien |0 (DE-588)4022153-2 |2 gnd |9 rswk-swf | |
651 | 7 | |a Niederlande |0 (DE-588)4042203-3 |2 gnd |9 rswk-swf | |
651 | 7 | |a Deutschland |0 (DE-588)4011882-4 |2 gnd |9 rswk-swf | |
689 | 0 | 0 | |a Europäische Gemeinschaften |0 (DE-588)35439-9 |D b |
689 | 0 | 1 | |a Arzneimittelmarkt |0 (DE-588)4003131-7 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Deutschland |0 (DE-588)4011882-4 |D g |
689 | 1 | 1 | |a Arzneimittelhandel |0 (DE-588)4143178-9 |D s |
689 | 1 | 2 | |a Großbritannien |0 (DE-588)4022153-2 |D g |
689 | 1 | 3 | |a Niederlande |0 (DE-588)4042203-3 |D g |
689 | 1 | |8 1\p |5 DE-604 | |
710 | 2 | |a Europäische Kommission |e Sonstige |0 (DE-588)1024466-9 |4 oth | |
999 | |a oai:aleph.bib-bvb.de:BVB01-003892842 | ||
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk |
Datensatz im Suchindex
_version_ | 1804120383329140736 |
---|---|
any_adam_object | |
building | Verbundindex |
bvnumber | BV006154902 |
classification_rvk | PS 2860 QR 525 |
ctrlnum | (OCoLC)231433291 (DE-599)BVBBV006154902 |
discipline | Rechtswissenschaft Wirtschaftswissenschaften |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01954nam a2200481 cb4500</leader><controlfield tag="001">BV006154902</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19930817 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">930201s1992 d||| |||| 00||| und d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9282636607</subfield><subfield code="9">92-826-3660-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)231433291</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV006154902</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">und</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-384</subfield><subfield code="a">DE-12</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PS 2860</subfield><subfield code="0">(DE-625)139739:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Impediments to parallel trade in pharmaceuticals within the European Community</subfield><subfield code="b">final report</subfield><subfield code="c">prepared for DGIV of the European Commission by REMIT Consultants, London</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Luxembourg</subfield><subfield code="b">Office for Official Publ. of the Europ. Communities</subfield><subfield code="c">1992</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">85 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Document / Commission of the European Communities</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Deadline 92</subfield></datafield><datafield tag="610" ind1="2" ind2="7"><subfield code="a">Europäische Gemeinschaften</subfield><subfield code="0">(DE-588)35439-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelmarkt</subfield><subfield code="0">(DE-588)4003131-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelhandel</subfield><subfield code="0">(DE-588)4143178-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Großbritannien</subfield><subfield code="0">(DE-588)4022153-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Niederlande</subfield><subfield code="0">(DE-588)4042203-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Deutschland</subfield><subfield code="0">(DE-588)4011882-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Europäische Gemeinschaften</subfield><subfield code="0">(DE-588)35439-9</subfield><subfield code="D">b</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittelmarkt</subfield><subfield code="0">(DE-588)4003131-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Deutschland</subfield><subfield code="0">(DE-588)4011882-4</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittelhandel</subfield><subfield code="0">(DE-588)4143178-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Großbritannien</subfield><subfield code="0">(DE-588)4022153-2</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="1" ind2="3"><subfield code="a">Niederlande</subfield><subfield code="0">(DE-588)4042203-3</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Europäische Kommission</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)1024466-9</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-003892842</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
geographic | Großbritannien (DE-588)4022153-2 gnd Niederlande (DE-588)4042203-3 gnd Deutschland (DE-588)4011882-4 gnd |
geographic_facet | Großbritannien Niederlande Deutschland |
id | DE-604.BV006154902 |
illustrated | Illustrated |
indexdate | 2024-07-09T16:41:13Z |
institution | BVB |
institution_GND | (DE-588)1024466-9 |
isbn | 9282636607 |
language | Undetermined |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-003892842 |
oclc_num | 231433291 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR DE-384 DE-12 |
owner_facet | DE-355 DE-BY-UBR DE-384 DE-12 |
physical | 85 S. graph. Darst. |
publishDate | 1992 |
publishDateSearch | 1992 |
publishDateSort | 1992 |
publisher | Office for Official Publ. of the Europ. Communities |
record_format | marc |
series2 | Document / Commission of the European Communities Deadline 92 |
spelling | Impediments to parallel trade in pharmaceuticals within the European Community final report prepared for DGIV of the European Commission by REMIT Consultants, London Luxembourg Office for Official Publ. of the Europ. Communities 1992 85 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Document / Commission of the European Communities Deadline 92 Europäische Gemeinschaften (DE-588)35439-9 gnd rswk-swf Arzneimittelmarkt (DE-588)4003131-7 gnd rswk-swf Arzneimittelhandel (DE-588)4143178-9 gnd rswk-swf Großbritannien (DE-588)4022153-2 gnd rswk-swf Niederlande (DE-588)4042203-3 gnd rswk-swf Deutschland (DE-588)4011882-4 gnd rswk-swf Europäische Gemeinschaften (DE-588)35439-9 b Arzneimittelmarkt (DE-588)4003131-7 s DE-604 Deutschland (DE-588)4011882-4 g Arzneimittelhandel (DE-588)4143178-9 s Großbritannien (DE-588)4022153-2 g Niederlande (DE-588)4042203-3 g 1\p DE-604 Europäische Kommission Sonstige (DE-588)1024466-9 oth 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | Impediments to parallel trade in pharmaceuticals within the European Community final report Europäische Gemeinschaften (DE-588)35439-9 gnd Arzneimittelmarkt (DE-588)4003131-7 gnd Arzneimittelhandel (DE-588)4143178-9 gnd |
subject_GND | (DE-588)35439-9 (DE-588)4003131-7 (DE-588)4143178-9 (DE-588)4022153-2 (DE-588)4042203-3 (DE-588)4011882-4 |
title | Impediments to parallel trade in pharmaceuticals within the European Community final report |
title_auth | Impediments to parallel trade in pharmaceuticals within the European Community final report |
title_exact_search | Impediments to parallel trade in pharmaceuticals within the European Community final report |
title_full | Impediments to parallel trade in pharmaceuticals within the European Community final report prepared for DGIV of the European Commission by REMIT Consultants, London |
title_fullStr | Impediments to parallel trade in pharmaceuticals within the European Community final report prepared for DGIV of the European Commission by REMIT Consultants, London |
title_full_unstemmed | Impediments to parallel trade in pharmaceuticals within the European Community final report prepared for DGIV of the European Commission by REMIT Consultants, London |
title_short | Impediments to parallel trade in pharmaceuticals within the European Community |
title_sort | impediments to parallel trade in pharmaceuticals within the european community final report |
title_sub | final report |
topic | Europäische Gemeinschaften (DE-588)35439-9 gnd Arzneimittelmarkt (DE-588)4003131-7 gnd Arzneimittelhandel (DE-588)4143178-9 gnd |
topic_facet | Europäische Gemeinschaften Arzneimittelmarkt Arzneimittelhandel Großbritannien Niederlande Deutschland |
work_keys_str_mv | AT europaischekommission impedimentstoparalleltradeinpharmaceuticalswithintheeuropeancommunityfinalreport |